Amarpreet Sawhney, President and CEO at OCULAR THERAPEUTIX, INC (OCUL), bought 10,000 shares at $6.70 ($67K) on 2016-06-09, disclosed to the SEC on 2016-06-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OCUL | BUY | 2017-11-20 | $98K | — | Filing → |
| OCUL | BUY | 2016-12-16 | $356K | — | Filing → |
| OCUL | BUY | 2015-11-18 | $83K | — | Filing → |